Patents by Inventor Shmuel Bentov

Shmuel Bentov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10328100
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: June 25, 2019
    Assignee: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • Publication number: 20160045546
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: June 19, 2015
    Publication date: February 18, 2016
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel BENTOV, Amir SAGI, Amir BERMAN, Assaf SHECHTER
  • Patent number: 9021878
    Abstract: The present invention is flow rate meters which are able to accurately measure the volumetric rate of flow of a liquid through a conduit without requiring foreknowledge of the physicochemical characteristics of the liquid, e.g., for the purpose of calibration of the thermal mass flow rate. One application of the flow meters of the invention is to incorporate them in a system for measuring the flow rate of urine excreted by a catheterized patient. The invention also provides methods for using the flow rate meters.
    Type: Grant
    Filed: April 4, 2011
    Date of Patent: May 5, 2015
    Assignee: Renalsense Ltd.
    Inventors: Mor Grinstein, Jack Yehoshua Mantinband, Shmuel Bentov, Michael Adler
  • Patent number: 8802160
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid which stabilizes the amorphous form of said calcium carbonate. The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Grant
    Filed: October 22, 2008
    Date of Patent: August 12, 2014
    Assignee: Amorphical Ltd.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • Publication number: 20130041234
    Abstract: The present invention is flow rate meters which are able to accurately measure the volumetric rate of flow of a liquid through a conduit without requiring foreknowledge of the physicochemical characteristics of the liquid, e.g., for the purpose of calibration of the thermal mass flow rate. One application of the flow meters of the invention is to incorporate them in a system for measuring the flow rate of urine excreted by a catheterized patient. The invention also provides methods for using the flow rate meters.
    Type: Application
    Filed: April 4, 2011
    Publication date: February 14, 2013
    Applicants: RENALSENSE LTD., RENALSENSE LTD., RENALSENSE LTD., RENALSENSE LTD.
    Inventors: Mor Grinstein, Jack Yehoshua Mantinband, Shmuel Bentov, Michael Adler
  • Publication number: 20100310677
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated amino acid which stabilizes the amorphous form of said calcium carbonate. The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: October 22, 2008
    Publication date: December 9, 2010
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter
  • Publication number: 20100221362
    Abstract: Provided are compositions containing amorphous calcium carbonate (ACC), and at least one phosphorylated peptide which stabilizes the amorphous form of said calcium carbonate. Particularly, the peptide can be selected from crustacean proteins, also provided by the invention, namely GAP65, GAP22, GAP21, and GAP12 (also indicated herein as GAP10). The compositions are useful in pharmaceutical and nutraceutical formulations.
    Type: Application
    Filed: April 22, 2010
    Publication date: September 2, 2010
    Applicant: AMORPHICAL LTD.
    Inventors: Shmuel Bentov, Amir Sagi, Amir Berman, Assaf Shechter